|
|
||||||||
43.21 |
9
2 T cells1 Molecular Microbiology and Immunology, 2 Internal Medicine, St. Louis University, 3635 Vista Ave FDT 8N, St. Louis, MO, 63110
Abstract
Human
9
2 T cells expand and produce protective cytokine and cytolytic responses during mycobacterial infection.
9
2 T cells are also stimulated by nonpeptidic phosphoantigens (i.e-IPP, HMB-PP), expressed by intracellular mycobacteria and infected cells. Therefore, purified phosphoantigens could be useful components of new vaccines or immunotherapeutics by stimulating protective
9
2 T cells. However, it is unclear whether
9
2 T cells induced by phosphoantigens can protect against mycobacterial replication. We show that while BCG-expanded
9
2 T cells potently inhibit intracellular mycobacterial growth, IPP/HMB-PP-expanded
9
2 T cells fail to inhibit intracellular mycobacteria, although both lyse Daudi targets. TLR co-stimulation during IPP expansion also failed to induce anti-mycobacterial
9
2 T cells. TCR spectratyping and CDR3 sequencing demonstrated that BCG-expanded
9
2 T cells expressed significantly less TCR sequence diversity than IPP-expanded
9
2 T cells. BCG-expanded
9
2 T cells respond similarly to BCG- and IPP-stimulation, while IPP-expanded
9
2 T cells responded poorly to BCG. BCG appears to stimulate an antigen-specific focusing event in
9
2 T cells while IPP acts like a mitogen with broad
9
2 T cell reactivity. The antigens and/or co-stimulatory signals required to induce protective
9
2 T cells remain to be identified.
Support: NIH R01-AI-48391, VTEU NO1-AI-25464
| ||||||||||||||||||||||||||||||||||||||||